Literature DB >> 16682600

Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.

Robert Wirthlin1, Alice Song, Julia Song, Philip J Rosenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682600     DOI: 10.1001/archopht.124.5.741

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

Review 1.  Current approach in the diagnosis and management of posterior uveitis.

Authors:  S Sudharshan; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

2.  Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.

Authors:  Salim Ben Yahia; Carl P Herbort; Salah Jenzeri; Kamel Hmidi; Sonia Attia; Riadh Messaoud; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2008-04-10       Impact factor: 2.031

3.  Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.

Authors:  Nikunj J Shah; Urmi N Shah
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

4.  Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomography.

Authors:  Yanling Ouyang; Fuqiang Li; Qing Shao; Florian M Heussen; Pearse A Keane; Nicole Stübiger; Srinivas R Sadda; Uwe Pleyer
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis.

Authors:  Sharat Hegde; Nidhi Relhan; Avinash Pathengay; Abhishek Bawdekar; Himadri Choudhury; Animesh Jindal; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-07-12

Review 6.  Pediatric uveitis: An update.

Authors:  Parthopratim Dutta Majumder; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.